Automation Is No Longer Optional In Pharmacovigilance The pharmacovigilance landscape is entering a new phase of transformation. As adverse event volumes continue to rise and
The real PSMF problem has little to do with templates, version control, or how fast a document can be assembled. It is a problem of
Qinecsa Chief Operating Officer, John Cogan, has been featured in Journal of Clinical Studies latest issue, where he shares insights on priorities for quantitative signal
The FDA’s recent announcement on advancing real‑time clinical trials marks a significant shift in how the industry approaches safety surveillance, explains Jon Messer, VP Product
Qinecsa VP, Product Management QVW, Jon Messer, has been featured in Market Pathway’s latest issue, where he discusses the changes to medical device complaint handling
Qinecsa VP, Product Management QVW, Jon Messer, has been featured in MedTech Intelligence’s latest issue, where he discusses continuous safety surveillance for medical devices. Read
Chemistry Today asks Daniel O’Keeffe of Qinecsa Solutions if patient outcomes are getting lost in safety data complexity in a recent article. Daniel explores where AI
HaloPV is advanced pharmacovigilance technology that streamlines case management, signal detection and compliance to keep patient safety first worldwide.
Qinecsa VP, Product Management QVW, Jon Messer, has been featured in chemistry Today’s latest issue, where he discusses why 2026 is the inflection point for
Qinecsa Chief Product Officer, Beena Wood, has been featured in Pharm Tech’s latest issue, where she outlines how proactive PV, translational safety, AI foundations, and
